References

Cancer statistics for African American and Black people, 2025

10.3322/caac.21874 · 2025 · External reference

Cancer statistics, 2026

2026 · External reference

The contribution of race to breast tumor microenvironment composition and disease progression

10.3389/fonc.2020.01022 · 2020 · External reference

Deconstructing racial and ethnic disparities in breast cancer

10.1001/jamaoncol.2020.7113 · 2021 · External reference

Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group

10.1093/jnci/djp175 · 2009 · External reference

Racial disparity in distant recurrence-free survival in patients with localized breast cancer: a pooled analysis of National Surgical Adjuvant Breast and Bowel Project trials

10.1002/cncr.34241 · 2022 · External reference

Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial

10.1093/jnci/djr543 · 2012 · External reference

Impact of genetic ancestry on outcomes in ECOG-ACRIN-E5103

10.1200/po.17.00059 · 2017 · External reference

Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer

10.1056/nejmoa1804710 · 2018 · External reference

21-gene assay to inform chemotherapy benefit in node-positive breast cancer

10.1056/nejmoa2108873 · 2021 · External reference

Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: ASCO clinical practice guideline update-integration of results from TAILORx

10.1200/jco.19.00945 · 2019 · External reference

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

10.1016/j.annonc.2023.11.016 · 2024 · External reference

NCCN Guidelines® insights: breast cancer, version 5.2025

10.6004/jnccn.2025.0053 · 2025 · External reference

Molecular drivers of oncotype DX, Prosigna, EndoPredict, and the breast cancer index: a TransATAC Study

10.1200/jco.20.00853 · 2021 · External reference

Association of race/ethnicity and the 21-gene recurrence score with breast cancer-specific mortality among US women

10.1001/jamaoncol.2020.7320 · 2021 · External reference

Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial

10.1093/jnci/djae314 · 2025 · External reference

Recurrence Score® gene group components and outcomes in the RxPONDER trial (SWOG S1007)

10.1093/jnci/djag221 · 2026 · External reference

Relationship between topoisomerase 2A RNA expression and recurrence after adjuvant chemotherapy for breast cancer

10.1158/1078-0432.ccr-09-1450 · 2009 · External reference

Race, ethnicity, and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer in the randomized TAILORx trial

10.1093/jnci/djaa148 · 2021 · External reference

Impact of race/ethnicity on MammaPrint genomic assay risk and prognosis in early breast cancer: a National Cancer Data Base analysis

10.1002/cncr.35771 · 2025 · External reference

Abstract P2-10-08: racial disparities in breast cancer: identifying predisposing clinical and molecular features associated with African American patients

10.1158/1538-7445.sabcs19-p2-10-08 · 2020 · External reference